glp-1 interactions Understanding receptor agonists and their impact on drug discovery Role of glucagon-like peptide (GLP-1)
Description
The effects of weight loss drugs stop when the user goes off of them

doi: 10.1038/nm.4236 101 PsichasA.SleethM

What the GLP-1 ID Program Includes: The GLP-1 ID program includes personalized medical evaluation and prescription management, with individualized dosing of compounded semaglutide or compounded tirzepatide based on your specific response and tolerance
MNT incorporates individualized nutrition assessment, diagnostics, therapy, and counseling to modify dietary behaviors, manage health conditions, and enhance well-being

It included a box warning regarding the risk of thyroid C-cell tumors with contraindications for patients with: A personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 Serious hypersensitivity to tirzepatide or any Zepbound excipients Monitoring is encouraged to look for symptoms of thyroid tumors, such as a lump in the neck, unexplained hoarseness, trouble swallowing, and shortness of breath

Kooij IA, Sahami S, Meijer SL, et al
